Brief: Metavia Announces Ai-Driven Collaboration With Syntekabio To Explore Additional Indications For Da-1241
04/08/2025 14:09
Aug 4 (Reuters) - SyntekaBio Inc 226330.KQ: METAVIA ANNOUNCES AI-DRIVEN COLLABORATION WITH SYNTEKABIO TO EXPLORE ADDITIONAL INDICATIONS FOR DA-1241 Source text: ID:nPn8VGlB3a Further company coverage: 226330.KQ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syntekabio
See all newsBrief: Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel
Brief: Syntekabio Wins 397 Million Won Order
Brief: Syntekabio To Conduct Capital Increase Of 32 Billion Won
Brief: Metavia Announces Ai-Driven Collaboration With Syntekabio To Explore Additional Indications For Da-1241